BOTHELL, WA, July 30, 2002 - Sonosite, Inc. (Nasdaq: SONO) today announced that, effective August 5, Jens U. Quistgaard, Ph.D., Sonosite's chief product and strategy officer, will leave the Company to become the president and chief executive officer of LipoSonix, Inc., a private company based in the Seattle area.
LipoSonix is developing medical devices for cosmetic surgery applications and is not a Sonosite competitor. "Jens has been with Sonosite since the beginning when we were the Handheld Systems Business Group at ATL Ultrasound five years ago," said Kevin M. Goodwin, Sonosite's president and CEO.
"Under his leadership, our product development and marketing groups have delivered ground-breaking products and strong market progress. Jens deserves an opportunity like this, and we wish him the best. "Blake Little, vice president of engineering, will become the Company's senior engineering officer and technology spokesperson," Goodwin continued. "Blake has been instrumental in the development and release of all of Sonosite's products, including our newest product line that we will be launching in the next several weeks.